<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="Microbiology, Immunology, and Infection1684-11821995-9133Taiwan Society of Microbiology. Published by Elsevier" exact="Taiwan" post="LLC. pmcid: 7129535S1684-1182(20)30094-3 doi: 10.1016/j.jmii.2020.03.034 : Article Treatment options"/>
 <result pre="âˆ—Corresponding author. Departments of Laboratory Medicine and Internal Medicine, National" exact="Taiwan" post="University Hospital, National Taiwan University College of Medicine, No."/>
 <result pre="Laboratory Medicine and Internal Medicine, National Taiwan University Hospital, National" exact="Taiwan" post="University College of Medicine, No. 7 Chung-Shan South Road,"/>
 <result pre="respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan," exact="China" post="in December 2019. An extremely high potential for dissemination"/>
 <result pre="by the Centers for Disease Control (CDC) and Prevention of" exact="Taiwan" post="since February, 2020. According to an investigation by To"/>
 <result pre="in humans are available online.21 The first COVID-19 patient in" exact="the USA" post="was successfully treated with remdesivir for the progression of"/>
 <result pre="infection.28 Favipiravir was approved for the treatment of COVID-19 in" exact="China" post="in March, 2020. In addition, patients with COVID-19 infection"/>
 <result pre="serum level.31,33 A randomized, controlled open-label trial was launched in" exact="China" post="to evaluate the efficacy of LPV/RTV (200/50 mg twice"/>
 <result pre="advance) to chloroquine phosphate in inhibiting SARS-CoV-2 in vitro.41 The" exact="Taiwan" post="CDC declared hydroxychloroquine as an important anti-SARS-CoV-2 agent on"/>
 <result pre="of stem cells against COVID-19 has been under evaluation in" exact="China" post="recently. Additionally, tocilizumab (Roche Pharmaceuticals, Basel, Switzerland) is a"/>
 <result pre="absence of ARDS is advised. Additionally, despite conflicting advice from" exact="the US" post="Food and Drug Administration,65 the use of non-steroidal anti-inflammatory"/>
 <result pre="monitoring of persons exposed to patients with confirmed COVID-19 -" exact="United States," post="January-February 2020MMWR Morb Mortal Wkly Rep69202024524632134909 8LiuJ.LiuY.XiangP.PuL.XiongH.LiC.Neutrophil-to-lymphocyte ratio predicts"/>
</results>
